Can I take red yeast rice safely?

Red yeast rice contains natural statins that can lower cholesterol but carries similar risks to prescription statins including muscle pain and liver issues. Always consult a healthcare provider before use, especially if taking other medications.

Questions on this topic?Ask Sai, our AI longevity expert.
Ask Sai

What Is Red Yeast Rice?

Red yeast rice is a traditional Chinese culinary and medicinal product made by fermenting white rice with the yeast Monascus purpureus. This fermentation process gives the rice its characteristic reddish-purple color and produces several compounds, including monacolins, that have cholesterol-lowering properties. The most notable of these compounds is monacolin K, which is chemically identical to lovastatin, a prescription statin medication.

For centuries, red yeast rice has been used in Traditional Chinese Medicine to promote blood circulation and digestive health. Today, it's marketed as a dietary supplement for managing cholesterol levels and supporting cardiovascular health. However, its similarity to prescription medications raises important questions about safety, efficacy, and proper use.

How Red Yeast Rice Works in Your Body

Red yeast rice works primarily through its monacolin K content, which inhibits HMG-CoA reductase, an enzyme crucial for cholesterol production in the liver. This mechanism is identical to how prescription statins work. By blocking this enzyme, red yeast rice can reduce the liver's production of cholesterol, particularly LDL cholesterol, often called 'bad' cholesterol.

Red Yeast Rice Side Effects by Severity

Side effect frequencies are estimates based on statin data, as specific data for red yeast rice is limited.
Severity LevelSymptomsFrequencyAction Required
MildMildHeadache, gas, bloating, dizzinessCommon (10-20%)Monitor, may resolve with continued use
ModerateModerateMuscle aches, elevated liver enzymes, heartburnUncommon (2-5%)Consult healthcare provider, may need dose adjustment
SevereSevereRhabdomyolysis, liver damage, severe muscle painRare (<1%)Stop immediately, seek medical attention

Side effect frequencies are estimates based on statin data, as specific data for red yeast rice is limited.

Studies have shown that red yeast rice can reduce LDL cholesterol by 15-25% and total cholesterol by 10-20% when taken consistently. Some research also suggests modest improvements in HDL cholesterol and triglyceride levels. The effectiveness varies significantly based on the product's monacolin K content, which can range from 0.4 to 10 mg per daily dose. If you're considering red yeast rice for cholesterol management, getting baseline cholesterol levels through comprehensive testing can help you track your progress effectively.

Active Compounds Beyond Monacolin K

While monacolin K gets most of the attention, red yeast rice contains other bioactive compounds including sterols, isoflavones, and monounsaturated fatty acids. These compounds may contribute additional cardiovascular benefits through anti-inflammatory and antioxidant effects. However, the variability in these compounds across different products makes it challenging to predict their therapeutic impact.

Safety Concerns and Side Effects

The safety profile of red yeast rice mirrors that of prescription statins, which isn't surprising given their chemical similarity. Common side effects include headaches, dizziness, heartburn, and gas. More concerning are the potential serious side effects that, while rare, require careful monitoring and awareness.

The most common serious concern with red yeast rice is muscle pain and weakness, medically known as myopathy. This can range from mild muscle aches to severe muscle breakdown (rhabdomyolysis), a rare but life-threatening condition. Risk factors for muscle problems include higher doses, concurrent use of certain medications, kidney disease, and genetic factors. If you experience unexplained muscle pain, weakness, or dark-colored urine while taking red yeast rice, discontinue use immediately and consult your healthcare provider.

Liver Function Impact

Red yeast rice can affect liver enzymes, potentially indicating liver stress or damage. While serious liver problems are rare, monitoring liver function through blood tests is recommended, especially during the first few months of use. Signs of liver problems include fatigue, loss of appetite, upper abdominal pain, dark urine, or yellowing of the skin or eyes.

Regular monitoring of liver enzymes like ALT and AST can help detect any issues early.

Drug Interactions to Watch For

Red yeast rice can interact with numerous medications, potentially increasing the risk of side effects or reducing effectiveness of treatments. The most significant interactions occur with drugs that are metabolized by the same liver enzyme system (CYP3A4) or that increase the risk of muscle problems.

  • Statins and other cholesterol medications: Combining red yeast rice with prescription statins dramatically increases the risk of muscle damage and liver problems
  • Blood thinners like warfarin: May increase bleeding risk
  • Certain antibiotics and antifungals: Can increase monacolin K levels in the blood
  • Grapefruit juice: Can increase absorption and side effect risk
  • Fibrates and niacin: Increase risk of muscle problems when combined
  • Cyclosporine and other immunosuppressants: May interact and increase toxicity risk

Additionally, red yeast rice should not be taken with alcohol in excess, as this combination may increase the risk of liver damage. If you're taking any prescription medications, consult your healthcare provider before starting red yeast rice supplementation.

Upload your blood test results to track your progress

Seamlessly upload 3rd party biomarker & blood tests to track your whole health in 1 dashboard. Understand what each blood test means and how it fits into the bigger picture of your body and health.

Get diet and lifestyle recommendations based on your blood results, health profile and health goals. You'll also receive a custom supplement recommendation for the precise nutrients your body craves.

Upload Past Blood Test Results

Click or drag file to upload

Once you upload your report, we'll extract the results for your review. Works with top labs including Quest Diagnostics, LabCorp, BioReference, EverlyWell, LetsGetChecked and hundreds of other labs.

Who Should Avoid Red Yeast Rice?

Certain individuals should avoid red yeast rice entirely due to increased risk of complications. Understanding these contraindications is crucial for safe use.

Pregnant and breastfeeding women should absolutely avoid red yeast rice, as statins (including the monacolin K in red yeast rice) can cause birth defects. Women of childbearing age should use reliable contraception while taking red yeast rice. People with liver disease, kidney disease, or a history of muscle disorders should also avoid this supplement.

Additionally, individuals who have experienced side effects from prescription statins are likely to have similar reactions to red yeast rice. Those scheduled for surgery should discontinue red yeast rice at least two weeks beforehand, as it may increase bleeding risk.

Quality and Regulation Challenges

One of the biggest safety concerns with red yeast rice is the lack of standardization and quality control in supplements. Studies have found dramatic variations in monacolin K content between products, with some containing none at all and others containing amounts equivalent to prescription medications. This inconsistency makes it difficult to predict both effectiveness and safety.

The FDA has taken action against some red yeast rice products that contain more than trace amounts of monacolin K, considering them unapproved drugs rather than dietary supplements. This has led some manufacturers to remove or reduce monacolin K content, potentially eliminating the cholesterol-lowering benefits while still marketing the product for heart health.

Contamination Risks

Another serious concern is contamination with citrinin, a toxic compound that can damage the kidneys. Citrinin can form during the fermentation process if not properly controlled. While reputable manufacturers test for citrinin, not all products undergo such testing. Look for products that are third-party tested and certified free of citrinin and other contaminants.

Safe Usage Guidelines

If you decide to use red yeast rice after consulting with your healthcare provider, following safe usage guidelines can minimize risks. Start with the lowest effective dose, typically 1,200-2,400 mg daily, divided into two doses with meals. This can help reduce gastrointestinal side effects and improve absorption.

Monitor your response carefully, including any side effects and changes in cholesterol levels. Regular blood testing every 3-6 months can help track your lipid levels and liver function. If you're interested in comprehensive monitoring of your cardiovascular health markers, including advanced cholesterol testing beyond standard panels, regular biomarker testing can provide valuable insights into your treatment response.

  • Choose products from reputable manufacturers that provide third-party testing results
  • Take with food to minimize stomach upset
  • Avoid grapefruit and excessive alcohol consumption
  • Stay hydrated and maintain regular physical activity
  • Report any unusual symptoms to your healthcare provider immediately
  • Consider taking CoQ10 supplements, as statins can deplete this important nutrient

Alternatives to Consider

Before turning to red yeast rice, consider evidence-based lifestyle modifications that can significantly impact cholesterol levels without the risks associated with supplements. Dietary changes, including increasing soluble fiber intake, reducing saturated fat, and incorporating plant sterols, can lower LDL cholesterol by 5-15%. Regular aerobic exercise can improve HDL cholesterol while reducing LDL and triglycerides.

Other natural supplements with cholesterol-lowering effects and generally better safety profiles include psyllium husk, plant sterols and stanols, omega-3 fatty acids, and niacin (though niacin requires monitoring at therapeutic doses). For those needing more significant cholesterol reduction, prescription statins remain the gold standard, offering consistent dosing, proven cardiovascular benefits, and medical supervision.

For a personalized analysis of your existing cholesterol and cardiovascular health markers, you can upload your recent blood test results to SiPhox Health's free analysis service. This AI-powered tool provides clear insights into your current health status and actionable recommendations tailored to your unique profile.

Making an Informed Decision

The decision to use red yeast rice should be made carefully, considering your individual health status, risk factors, and treatment goals. While it can be an effective option for some people with mildly elevated cholesterol who cannot or prefer not to take prescription statins, it's not without risks. The lack of standardization, potential for serious side effects, and drug interactions make medical supervision essential.

Work with your healthcare provider to develop a comprehensive cardiovascular health plan that may include dietary changes, exercise, stress management, and appropriate supplementation or medication. Regular monitoring through blood tests can help ensure that any intervention is both safe and effective. Remember that managing cholesterol is just one aspect of cardiovascular health, and a holistic approach addressing all risk factors provides the best outcomes for long-term health and longevity.

References

  1. Gerards, M. C., Terlou, R. J., Yu, H., Koks, C. H., & Gerdes, V. E. (2015). Traditional Chinese lipid-lowering agent red yeast rice results in significant LDL reduction but safety is uncertain - a systematic review and meta-analysis. Atherosclerosis, 240(2), 415-423.[PubMed][DOI]
  2. Cohen, P. A., Avula, B., & Khan, I. A. (2017). Variability in strength of red yeast rice supplements purchased from mainstream retailers. European Journal of Preventive Cardiology, 24(13), 1431-1434.[PubMed][DOI]
  3. Cicero, A. F., Fogacci, F., & Banach, M. (2019). Red Yeast Rice for Hypercholesterolemia. Methodist DeBakey Cardiovascular Journal, 15(3), 192-199.[PubMed][DOI]
  4. Gordon, R. Y., Cooperman, T., Obermeyer, W., & Becker, D. J. (2010). Marked variability of monacolin levels in commercial red yeast rice products: buyer beware! Archives of Internal Medicine, 170(19), 1722-1727.[PubMed][DOI]
  5. Klimek, M., Wang, S., & Ogunkanmi, A. (2009). Safety and efficacy of red yeast rice (Monascus purpureus) as an alternative therapy for hyperlipidemia. P & T: A Peer-Reviewed Journal for Formulary Management, 34(6), 313-327.[PubMed]
  6. European Food Safety Authority (EFSA). (2018). Scientific opinion on the safety of monacolins in red yeast rice. EFSA Journal, 16(8), e05368.[DOI]

Was this article helpful?

Frequently Asked Questions

How can I test my cholesterol at home?

You can test your cholesterol at home with SiPhox Health's Heart & Metabolic Program. This CLIA-certified program includes comprehensive cholesterol testing including HDL, LDL, triglycerides, and ApoB, providing lab-quality results from the comfort of your home.

Is red yeast rice as effective as prescription statins?

Red yeast rice can lower LDL cholesterol by 15-25%, which is generally less than prescription statins (20-55%). However, effectiveness varies widely between products due to inconsistent monacolin K content. Prescription statins offer more predictable results and medical supervision.

How long does it take for red yeast rice to lower cholesterol?

Most people see initial cholesterol improvements within 4-12 weeks of consistent use. Maximum effects typically occur after 12 weeks. Regular blood testing every 3-6 months is recommended to monitor your response and adjust dosing if needed.

Can I take red yeast rice with other supplements?

While red yeast rice can be taken with many supplements, avoid combining it with other cholesterol-lowering supplements without medical guidance. CoQ10 supplementation is often recommended alongside red yeast rice, as statins can deplete CoQ10 levels. Always inform your healthcare provider about all supplements you're taking.

What's the difference between red yeast rice and regular rice?

Red yeast rice is white rice fermented with Monascus purpureus yeast, which produces monacolin K and other bioactive compounds. Regular rice doesn't contain these cholesterol-lowering compounds. The fermentation process is what gives red yeast rice its therapeutic properties and reddish color.

This article is licensed under CC BY 4.0. You are free to share and adapt this material with attribution.

Ask Questions About Any Health Topic

Chat with Sai, our AI health assistant, for personalized insights.

Click or drag file to upload blood test results

Backed By Leading Experts in Health Optimization

Tsolmon Tsogbayar, MD

Tsolmon Tsogbayar, MD

Health Programs Lead, Health Innovation

Dr. Tsogbayar leverages her clinical expertise to develop innovative health solutions and evidence-based coaching. Dr. Tsogbayar previously practiced as a physician with a comprehensive training background, developing specialized expertise in cardiology and emergency medicine after gaining experience in primary care, allergy & immunology, internal medicine, and general surgery.

She earned her medical degree from Imperial College London, where she also completed her MSc in Human Molecular Genetics after obtaining a BSc in Biochemistry from Queen Mary University of London. Her academic research includes significant work in developmental cardiovascular genetics, with her thesis publication contributing to the understanding of genetic modifications on embryonic cardiovascular development.

View Details
Pavel Korecky, MD

Pavel Korecky, MD

Director of Clinical Product Operations

Director of Clinical Product Operations at SiPhox Health with a background in medicine and a passion for health optimization. Experienced in leading software and clinical development teams, contributing to patents, launching health-related products, and turning diagnostics into actionable tools.

View Details
Paul Thompson, MD

Paul Thompson, MD

Advisor

Paul D. Thompson is Chief of Cardiology Emeritus of Hartford Hospital and Professor Emeritus at University of Connecticut Medical School. He has authored over 500 scientific articles on cardiovascular risk factors, the effects of exercise, and beyond. He received National Institutes of Health’s (NIH) Preventive Cardiology Academic Award, and has received NIH funding for multiple studies.

Dr. Thompson’s interests in exercise, general cardiology and sports cardiology originated from his own distance running: he qualified for the 1972 Olympic Marathon Trials as a 3rd year medical student and finished 16th in the 1976 Boston Marathon. Dr. Thompson publishes a blog 500 Rules of Cardiology where he shares lessons and anecdotes that he has learned over his extensive career as a physician, researcher and teacher.

View Details
Robert Lufkin, MD

Robert Lufkin, MD

Advisor

Physician/medical school professor (UCLA and USC) and New York Times bestselling author empowering people to take back their metabolic health with lifestyle and other tools. A veteran of the Today Show, USA Today, and a regular contributor to FOX and other network news stations, his weekly video podcast reaches over 500,000 people. After reversing chronic disease and transforming his own life he is making it his mission to help others do the same.

His latest book, ‘Lies I Taught In Medical School’ is an instant New York Times bestseller and has re-framed how we think about metabolic health and longevity. In addition to being a practicing physician, he is author of over 200 peer reviewed scientific papers and 14 books that are available in fourteen languages.

View Details
Ben Bikman, PhD

Ben Bikman, PhD

Advisor

Benjamin Bikman earned his Ph.D. in Bioenergetics and was a postdoctoral fellow with the Duke-National University of Singapore in metabolic disorders. Currently, his professional focus as a scientist and professor (Brigham Young University) is to better understand the role of elevated insulin and nutrient metabolism in regulating obesity, diabetes, and dementia.

In addition to his academic pursuits, Dr. Bikman is the author of Why We Get Sick and How Not To Get Sick.

View Details
Tash Milinkovic, MD

Tash Milinkovic, MD

Health Programs Lead, Heart & Metabolic

Dr. Natasha Milinkovic is part of the clinical product team at SiPhox Health, having graduated from the University of Bristol Medical School. Her medical career includes rotations across medical and surgical specialties, with specialized research in vascular surgery, focusing on recovery and post-operative pain outcomes. Dr. Milinkovic built her expertise in emergency medicine as a clinical fellow at a major trauma center before practicing at a central London teaching hospital throughout the pandemic.

She has contributed to global health initiatives, implementing surgical safety standards and protocols across rural Uganda. Dr. Milinkovic initially joined SiPhox Health to spearhead the health coaching initiative and has been a key contributor in the development and launch of the Heart and Metabolic program. She is passionate about addressing health disparities by building scalable healthcare solutions.

View Details
Tsolmon Tsogbayar, MD

Tsolmon Tsogbayar, MD

Health Programs Lead, Health Innovation

Dr. Tsogbayar leverages her clinical expertise to develop innovative health solutions and evidence-based coaching. Dr. Tsogbayar previously practiced as a physician with a comprehensive training background, developing specialized expertise in cardiology and emergency medicine after gaining experience in primary care, allergy & immunology, internal medicine, and general surgery.

She earned her medical degree from Imperial College London, where she also completed her MSc in Human Molecular Genetics after obtaining a BSc in Biochemistry from Queen Mary University of London. Her academic research includes significant work in developmental cardiovascular genetics, with her thesis publication contributing to the understanding of genetic modifications on embryonic cardiovascular development.

View Details
Pavel Korecky, MD

Pavel Korecky, MD

Director of Clinical Product Operations

Director of Clinical Product Operations at SiPhox Health with a background in medicine and a passion for health optimization. Experienced in leading software and clinical development teams, contributing to patents, launching health-related products, and turning diagnostics into actionable tools.

View Details
Paul Thompson, MD

Paul Thompson, MD

Advisor

Paul D. Thompson is Chief of Cardiology Emeritus of Hartford Hospital and Professor Emeritus at University of Connecticut Medical School. He has authored over 500 scientific articles on cardiovascular risk factors, the effects of exercise, and beyond. He received National Institutes of Health’s (NIH) Preventive Cardiology Academic Award, and has received NIH funding for multiple studies.

Dr. Thompson’s interests in exercise, general cardiology and sports cardiology originated from his own distance running: he qualified for the 1972 Olympic Marathon Trials as a 3rd year medical student and finished 16th in the 1976 Boston Marathon. Dr. Thompson publishes a blog 500 Rules of Cardiology where he shares lessons and anecdotes that he has learned over his extensive career as a physician, researcher and teacher.

View Details
Robert Lufkin, MD

Robert Lufkin, MD

Advisor

Physician/medical school professor (UCLA and USC) and New York Times bestselling author empowering people to take back their metabolic health with lifestyle and other tools. A veteran of the Today Show, USA Today, and a regular contributor to FOX and other network news stations, his weekly video podcast reaches over 500,000 people. After reversing chronic disease and transforming his own life he is making it his mission to help others do the same.

His latest book, ‘Lies I Taught In Medical School’ is an instant New York Times bestseller and has re-framed how we think about metabolic health and longevity. In addition to being a practicing physician, he is author of over 200 peer reviewed scientific papers and 14 books that are available in fourteen languages.

View Details
Ben Bikman, PhD

Ben Bikman, PhD

Advisor

Benjamin Bikman earned his Ph.D. in Bioenergetics and was a postdoctoral fellow with the Duke-National University of Singapore in metabolic disorders. Currently, his professional focus as a scientist and professor (Brigham Young University) is to better understand the role of elevated insulin and nutrient metabolism in regulating obesity, diabetes, and dementia.

In addition to his academic pursuits, Dr. Bikman is the author of Why We Get Sick and How Not To Get Sick.

View Details
Tash Milinkovic, MD

Tash Milinkovic, MD

Health Programs Lead, Heart & Metabolic

Dr. Natasha Milinkovic is part of the clinical product team at SiPhox Health, having graduated from the University of Bristol Medical School. Her medical career includes rotations across medical and surgical specialties, with specialized research in vascular surgery, focusing on recovery and post-operative pain outcomes. Dr. Milinkovic built her expertise in emergency medicine as a clinical fellow at a major trauma center before practicing at a central London teaching hospital throughout the pandemic.

She has contributed to global health initiatives, implementing surgical safety standards and protocols across rural Uganda. Dr. Milinkovic initially joined SiPhox Health to spearhead the health coaching initiative and has been a key contributor in the development and launch of the Heart and Metabolic program. She is passionate about addressing health disparities by building scalable healthcare solutions.

View Details
Tsolmon Tsogbayar, MD

Tsolmon Tsogbayar, MD

Health Programs Lead, Health Innovation

Dr. Tsogbayar leverages her clinical expertise to develop innovative health solutions and evidence-based coaching. Dr. Tsogbayar previously practiced as a physician with a comprehensive training background, developing specialized expertise in cardiology and emergency medicine after gaining experience in primary care, allergy & immunology, internal medicine, and general surgery.

She earned her medical degree from Imperial College London, where she also completed her MSc in Human Molecular Genetics after obtaining a BSc in Biochemistry from Queen Mary University of London. Her academic research includes significant work in developmental cardiovascular genetics, with her thesis publication contributing to the understanding of genetic modifications on embryonic cardiovascular development.

View Details
Pavel Korecky, MD

Pavel Korecky, MD

Director of Clinical Product Operations

Director of Clinical Product Operations at SiPhox Health with a background in medicine and a passion for health optimization. Experienced in leading software and clinical development teams, contributing to patents, launching health-related products, and turning diagnostics into actionable tools.

View Details
Paul Thompson, MD

Paul Thompson, MD

Advisor

Paul D. Thompson is Chief of Cardiology Emeritus of Hartford Hospital and Professor Emeritus at University of Connecticut Medical School. He has authored over 500 scientific articles on cardiovascular risk factors, the effects of exercise, and beyond. He received National Institutes of Health’s (NIH) Preventive Cardiology Academic Award, and has received NIH funding for multiple studies.

Dr. Thompson’s interests in exercise, general cardiology and sports cardiology originated from his own distance running: he qualified for the 1972 Olympic Marathon Trials as a 3rd year medical student and finished 16th in the 1976 Boston Marathon. Dr. Thompson publishes a blog 500 Rules of Cardiology where he shares lessons and anecdotes that he has learned over his extensive career as a physician, researcher and teacher.

View Details
Robert Lufkin, MD

Robert Lufkin, MD

Advisor

Physician/medical school professor (UCLA and USC) and New York Times bestselling author empowering people to take back their metabolic health with lifestyle and other tools. A veteran of the Today Show, USA Today, and a regular contributor to FOX and other network news stations, his weekly video podcast reaches over 500,000 people. After reversing chronic disease and transforming his own life he is making it his mission to help others do the same.

His latest book, ‘Lies I Taught In Medical School’ is an instant New York Times bestseller and has re-framed how we think about metabolic health and longevity. In addition to being a practicing physician, he is author of over 200 peer reviewed scientific papers and 14 books that are available in fourteen languages.

View Details
Ben Bikman, PhD

Ben Bikman, PhD

Advisor

Benjamin Bikman earned his Ph.D. in Bioenergetics and was a postdoctoral fellow with the Duke-National University of Singapore in metabolic disorders. Currently, his professional focus as a scientist and professor (Brigham Young University) is to better understand the role of elevated insulin and nutrient metabolism in regulating obesity, diabetes, and dementia.

In addition to his academic pursuits, Dr. Bikman is the author of Why We Get Sick and How Not To Get Sick.

View Details
Tash Milinkovic, MD

Tash Milinkovic, MD

Health Programs Lead, Heart & Metabolic

Dr. Natasha Milinkovic is part of the clinical product team at SiPhox Health, having graduated from the University of Bristol Medical School. Her medical career includes rotations across medical and surgical specialties, with specialized research in vascular surgery, focusing on recovery and post-operative pain outcomes. Dr. Milinkovic built her expertise in emergency medicine as a clinical fellow at a major trauma center before practicing at a central London teaching hospital throughout the pandemic.

She has contributed to global health initiatives, implementing surgical safety standards and protocols across rural Uganda. Dr. Milinkovic initially joined SiPhox Health to spearhead the health coaching initiative and has been a key contributor in the development and launch of the Heart and Metabolic program. She is passionate about addressing health disparities by building scalable healthcare solutions.

View Details
Tsolmon Tsogbayar, MD

Tsolmon Tsogbayar, MD

Health Programs Lead, Health Innovation

Dr. Tsogbayar leverages her clinical expertise to develop innovative health solutions and evidence-based coaching. Dr. Tsogbayar previously practiced as a physician with a comprehensive training background, developing specialized expertise in cardiology and emergency medicine after gaining experience in primary care, allergy & immunology, internal medicine, and general surgery.

She earned her medical degree from Imperial College London, where she also completed her MSc in Human Molecular Genetics after obtaining a BSc in Biochemistry from Queen Mary University of London. Her academic research includes significant work in developmental cardiovascular genetics, with her thesis publication contributing to the understanding of genetic modifications on embryonic cardiovascular development.

View Details
Pavel Korecky, MD

Pavel Korecky, MD

Director of Clinical Product Operations

Director of Clinical Product Operations at SiPhox Health with a background in medicine and a passion for health optimization. Experienced in leading software and clinical development teams, contributing to patents, launching health-related products, and turning diagnostics into actionable tools.

View Details
Paul Thompson, MD

Paul Thompson, MD

Advisor

Paul D. Thompson is Chief of Cardiology Emeritus of Hartford Hospital and Professor Emeritus at University of Connecticut Medical School. He has authored over 500 scientific articles on cardiovascular risk factors, the effects of exercise, and beyond. He received National Institutes of Health’s (NIH) Preventive Cardiology Academic Award, and has received NIH funding for multiple studies.

Dr. Thompson’s interests in exercise, general cardiology and sports cardiology originated from his own distance running: he qualified for the 1972 Olympic Marathon Trials as a 3rd year medical student and finished 16th in the 1976 Boston Marathon. Dr. Thompson publishes a blog 500 Rules of Cardiology where he shares lessons and anecdotes that he has learned over his extensive career as a physician, researcher and teacher.

View Details
Robert Lufkin, MD

Robert Lufkin, MD

Advisor

Physician/medical school professor (UCLA and USC) and New York Times bestselling author empowering people to take back their metabolic health with lifestyle and other tools. A veteran of the Today Show, USA Today, and a regular contributor to FOX and other network news stations, his weekly video podcast reaches over 500,000 people. After reversing chronic disease and transforming his own life he is making it his mission to help others do the same.

His latest book, ‘Lies I Taught In Medical School’ is an instant New York Times bestseller and has re-framed how we think about metabolic health and longevity. In addition to being a practicing physician, he is author of over 200 peer reviewed scientific papers and 14 books that are available in fourteen languages.

View Details
Ben Bikman, PhD

Ben Bikman, PhD

Advisor

Benjamin Bikman earned his Ph.D. in Bioenergetics and was a postdoctoral fellow with the Duke-National University of Singapore in metabolic disorders. Currently, his professional focus as a scientist and professor (Brigham Young University) is to better understand the role of elevated insulin and nutrient metabolism in regulating obesity, diabetes, and dementia.

In addition to his academic pursuits, Dr. Bikman is the author of Why We Get Sick and How Not To Get Sick.

View Details
Tash Milinkovic, MD

Tash Milinkovic, MD

Health Programs Lead, Heart & Metabolic

Dr. Natasha Milinkovic is part of the clinical product team at SiPhox Health, having graduated from the University of Bristol Medical School. Her medical career includes rotations across medical and surgical specialties, with specialized research in vascular surgery, focusing on recovery and post-operative pain outcomes. Dr. Milinkovic built her expertise in emergency medicine as a clinical fellow at a major trauma center before practicing at a central London teaching hospital throughout the pandemic.

She has contributed to global health initiatives, implementing surgical safety standards and protocols across rural Uganda. Dr. Milinkovic initially joined SiPhox Health to spearhead the health coaching initiative and has been a key contributor in the development and launch of the Heart and Metabolic program. She is passionate about addressing health disparities by building scalable healthcare solutions.

View Details
Tsolmon Tsogbayar, MD

Tsolmon Tsogbayar, MD

Health Programs Lead, Health Innovation

Dr. Tsogbayar leverages her clinical expertise to develop innovative health solutions and evidence-based coaching. Dr. Tsogbayar previously practiced as a physician with a comprehensive training background, developing specialized expertise in cardiology and emergency medicine after gaining experience in primary care, allergy & immunology, internal medicine, and general surgery.

She earned her medical degree from Imperial College London, where she also completed her MSc in Human Molecular Genetics after obtaining a BSc in Biochemistry from Queen Mary University of London. Her academic research includes significant work in developmental cardiovascular genetics, with her thesis publication contributing to the understanding of genetic modifications on embryonic cardiovascular development.

View Details
Pavel Korecky, MD

Pavel Korecky, MD

Director of Clinical Product Operations

Director of Clinical Product Operations at SiPhox Health with a background in medicine and a passion for health optimization. Experienced in leading software and clinical development teams, contributing to patents, launching health-related products, and turning diagnostics into actionable tools.

View Details
Paul Thompson, MD

Paul Thompson, MD

Advisor

Paul D. Thompson is Chief of Cardiology Emeritus of Hartford Hospital and Professor Emeritus at University of Connecticut Medical School. He has authored over 500 scientific articles on cardiovascular risk factors, the effects of exercise, and beyond. He received National Institutes of Health’s (NIH) Preventive Cardiology Academic Award, and has received NIH funding for multiple studies.

Dr. Thompson’s interests in exercise, general cardiology and sports cardiology originated from his own distance running: he qualified for the 1972 Olympic Marathon Trials as a 3rd year medical student and finished 16th in the 1976 Boston Marathon. Dr. Thompson publishes a blog 500 Rules of Cardiology where he shares lessons and anecdotes that he has learned over his extensive career as a physician, researcher and teacher.

View Details
Robert Lufkin, MD

Robert Lufkin, MD

Advisor

Physician/medical school professor (UCLA and USC) and New York Times bestselling author empowering people to take back their metabolic health with lifestyle and other tools. A veteran of the Today Show, USA Today, and a regular contributor to FOX and other network news stations, his weekly video podcast reaches over 500,000 people. After reversing chronic disease and transforming his own life he is making it his mission to help others do the same.

His latest book, ‘Lies I Taught In Medical School’ is an instant New York Times bestseller and has re-framed how we think about metabolic health and longevity. In addition to being a practicing physician, he is author of over 200 peer reviewed scientific papers and 14 books that are available in fourteen languages.

View Details
Ben Bikman, PhD

Ben Bikman, PhD

Advisor

Benjamin Bikman earned his Ph.D. in Bioenergetics and was a postdoctoral fellow with the Duke-National University of Singapore in metabolic disorders. Currently, his professional focus as a scientist and professor (Brigham Young University) is to better understand the role of elevated insulin and nutrient metabolism in regulating obesity, diabetes, and dementia.

In addition to his academic pursuits, Dr. Bikman is the author of Why We Get Sick and How Not To Get Sick.

View Details
Tash Milinkovic, MD

Tash Milinkovic, MD

Health Programs Lead, Heart & Metabolic

Dr. Natasha Milinkovic is part of the clinical product team at SiPhox Health, having graduated from the University of Bristol Medical School. Her medical career includes rotations across medical and surgical specialties, with specialized research in vascular surgery, focusing on recovery and post-operative pain outcomes. Dr. Milinkovic built her expertise in emergency medicine as a clinical fellow at a major trauma center before practicing at a central London teaching hospital throughout the pandemic.

She has contributed to global health initiatives, implementing surgical safety standards and protocols across rural Uganda. Dr. Milinkovic initially joined SiPhox Health to spearhead the health coaching initiative and has been a key contributor in the development and launch of the Heart and Metabolic program. She is passionate about addressing health disparities by building scalable healthcare solutions.

View Details